- Home
- MRK vs SRPT Comparison
MRK vs SRPT Comparison
Compare MRK & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- SRPT
- Stock Information
- Founded
- MRK 2000
- SRPT 1980
- Country
- MRK United States
- SRPT United States
- Employees
- MRK N/A
- SRPT N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- MRK Health Care
- SRPT Health Care
- Exchange
- MRK Nasdaq
- SRPT Nasdaq
- Market Cap
- MRK 198.5B
- SRPT 1.7B
- IPO Year
- MRK N/A
- SRPT 1997
- Fundamental
- Price
- MRK $83.70
- SRPT $19.23
- Analyst Decision
- MRK Buy
- SRPT Buy
- Analyst Count
- MRK 15
- SRPT 25
- Target Price
- MRK $113.14
- SRPT $61.57
- AVG Volume (30 Days)
- MRK 17.9M
- SRPT 7.9M
- Earning Date
- MRK 07-29-2025
- SRPT 08-06-2025
- Dividend Yield
- MRK 3.87%
- SRPT N/A
- EPS Growth
- MRK 667.14
- SRPT N/A
- EPS
- MRK 6.88
- SRPT N/A
- Revenue
- MRK $63,922,000,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- MRK $2.42
- SRPT $26.87
- Revenue Next Year
- MRK $5.77
- SRPT $3.15
- P/E Ratio
- MRK $12.17
- SRPT N/A
- Revenue Growth
- MRK 4.10
- SRPT 59.15
- 52 Week Low
- MRK $73.31
- SRPT $16.88
- 52 Week High
- MRK $129.03
- SRPT $154.13
- Technical
- Relative Strength Index (RSI)
- MRK 61.93
- SRPT 33.14
- Support Level
- MRK $82.26
- SRPT $17.95
- Resistance Level
- MRK $85.00
- SRPT $19.74
- Average True Range (ATR)
- MRK 1.84
- SRPT 1.09
- MACD
- MRK 0.36
- SRPT 0.97
- Stochastic Oscillator
- MRK 81.05
- SRPT 80.76
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.